Ameriprise
RDUS

Ameriprise’s Radius Health, Inc. RDUS Stock Holding History

Ameriprise’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-74,447
Closed -$515K – 4065
2021
Q4 		$515K Buy
+74,447
New +$1.09M ﹤0.01% 3516
2021
Q2 		– Sell
-34,764
Closed -$725K – 4002
2021
Q1 		$725K Sell
34,764
-30,534
-47% -$644K ﹤0.01% 3269
2020
Q4 		$1.17M Sell
65,298
-20,879
-24% -$314K ﹤0.01% 3015
2020
Q3 		$978K Sell
86,177
-90
-0.1% -$1.11K ﹤0.01% 2980
2020
Q2 		$1.18M Buy
86,267
+1,007
+1% +$13.9K ﹤0.01% 2860
2020
Q1 		$1.11M Buy
85,260
+3,848
+5% +$68.6K ﹤0.01% 2771
2019
Q4 		$1.64M Buy
81,412
+818
+1% +$19.9K ﹤0.01% 2831
2019
Q3 		$2.07M Sell
80,594
-15,232
-16% -$373K ﹤0.01% 2676
2019
Q2 		$2.33M Sell
95,826
-81,820
-46% -$1.79M ﹤0.01% 2654
2019
Q1 		$3.54M Buy
+177,646
New +$3.24M ﹤0.01% 2441
2018
Q2 		– Sell
-5,611
Closed -$202K – 3724
2018
Q1 		$202K Buy
+5,611
New +$203K ﹤0.01% 3482
2017
Q2 		– Sell
-22,216
Closed -$859K – 3815
2017
Q1 		$859K Sell
22,216
-9,250
-29% -$388K ﹤0.01% 2972
2016
Q4 		$1.2M Sell
31,466
-24,273
-44% -$1.16M ﹤0.01% 2884
2016
Q3 		$3.02M Buy
55,739
+13,758
+33% +$699K ﹤0.01% 2347
2016
Q2 		$1.54M Buy
41,981
+24,345
+138% +$860K ﹤0.01% 2654
2016
Q1 		$554K Sell
17,636
-43,407
-71% -$1.5M ﹤0.01% 3120
2015
Q4 		$3.76M Buy
61,043
+26,411
+76% +$1.67M ﹤0.01% 2229
2015
Q3 		$2.4M Buy
34,632
+22,822
+193% +$1.59M ﹤0.01% 2514
2015
Q2 		$799K Buy
+11,810
New +$550K ﹤0.01% 3229

Other funds holding RDUS

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise's RDUS Position: Q1 2022 in Review

Ameriprise sold out of Radius Health, Inc. (RDUS) in Q1 2022, closing a stake of 74,447 shares — an estimated $515K sold.

Ameriprise first reported a position in RDUS in Q2 2015 and held it in 19 quarters. The position peaked at $3.76M in Q4 2015. 138 funds tracked by Wall St. Rank hold RDUS as of Q1 2022.

  • Ameriprise reported no remaining Radius Health, Inc. position as of Q1 2022 after selling out during the quarter.
  • Ameriprise sold 74,447 Radius Health, Inc. shares in Q1 2022, an estimated $515K.
  • Ameriprise first reported a position in Radius Health, Inc. in Q2 2015 and held it in 19 quarters.
  • Ameriprise's Radius Health, Inc. position peaked at $3.76M in Q4 2015.
  • 138 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2022.

Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.